Effects of N–1-Mer Impurities in Antisense Oligonucleotides on the Target RNA Suppression

In this study, we focused on N-1 impurities in antisense oligonucleotides. We evaluated their binding affinity to the therapeutic target RNA, which had the complementary sequence to the full-length N-mer desired product (DP), and their ability to recruit ribonuclease H (RNase H) using cell-free <i>in vitro</i> assays. The binding affinity of each N-1-mer to the target RNA was extremely low, with binding constants <1: 100 of that of the DP/RNA duplex. However, the degree of destabilization varied significantly depending on the position of the nucleotide defect within the N-1-mer, with differences of up to 5.1 kcal/mol (a 4,000-fold difference in binding constant). This weak binding capability to the target RNA suggests that the presence of the N-1-mer has little effect on DP activity. This study provides essential information for the dissemination of oligonucleotide therapeutics by providing a basis for considering the effect of N-1-mer impurities.

Authors

Institutions

Publication Details

Journal
Nucleic Acid Therapeutics
Published
2026-02-04
DOI
https://doi.org/10.1177/21593337261419436
Primary Topic
DNA and Nucleic Acid Chemistry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of N–1-Mer Impurities in Antisense Oligonucleotides on the Target RNA Suppression

Nae Sakimoto, Tomoka Akita, Obika Satoshi, Shigenori Iwai et al.
Nucleic Acid Therapeutics
DNA and Nucleic Acid Chemistry
article

Effects of N–1-Mer Impurities in Antisense Oligonucleotides on the Target RNA Suppression

Nae Sakimoto, Tomoka Akita, Obika Satoshi, Shigenori Iwai, Hirokazu Nankai, Elisa Tomita-Sudo, Takao Inoue, Junji Kawakami, Renshin Sano
article en

Abstract

In this study, we focused on N-1 impurities in antisense oligonucleotides. We evaluated their binding affinity to the therapeutic target RNA, which had the complementary sequence to the full-length N-mer desired product (DP), and their ability to recruit ribonuclease H (RNase H) using cell-free <i>in vitro</i> assays. The binding affinity of each N-1-mer to the target RNA was extremely low, with binding constants <1: 100 of that of the DP/RNA duplex. However, the degree of destabilization varied significantly depending on the position of the nucleotide defect within the N-1-mer, with differences of up to 5.1 kcal/mol (a 4,000-fold difference in binding constant). This weak binding capability to the target RNA suggests that the presence of the N-1-mer has little effect on DP activity. This study provides essential information for the dissemination of oligonucleotide therapeutics by providing a basis for considering the effect of N-1-mer impurities.

Nucleic Acid Therapeutics
Osaka Gakuin University (JP), Konan University (JP), Ajinomoto (United States) (US), Ajinomoto (Japan) (JP), National Institute of Health Sciences (JP), The University of Osaka (JP)
Openalex Percentile: Top 68%
DNA and Nucleic Acid Chemistry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effects of N–1-Mer Impurities in Antisense Oligonucleotides on the Target RNA Suppression — Nae Sakimoto, Tomoka Akita, et al. · Nucleic Acid Therapeutics (2026) | TGRS Research Map | TGRS